CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $47.21 million. The enterprise value is $34.28 million.

Market Cap	47.21M
Enterprise Value	34.28M

Important Dates

The next estimated earnings date is Friday, August 7, 2026, before market open.

Earnings Date	Aug 7, 2026
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 13.53 million shares outstanding. The number of shares has increased by 5.45% in one year.

Current Share Class	13.53M
Shares Outstanding	13.53M
Shares Change (YoY)	+5.45%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	28.99%
Owned by Institutions (%)	13.11%
Float	9.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.60
Forward PS	98.64
PB Ratio	3.04
P/TBV Ratio	4.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.36

Current Ratio	3.36
Quick Ratio	2.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.76% and return on invested capital (ROIC) is -85.92%.

Return on Equity (ROE)	-132.76%
Return on Assets (ROA)	-72.41%
Return on Invested Capital (ROIC)	-85.92%
Return on Capital Employed (ROCE)	-292.99%
Weighted Average Cost of Capital (WACC)	-20.71%
Revenue Per Employee	$139,268
Profits Per Employee	-$2.00M
Employee Count	15
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.83% in the last 52 weeks. The beta is -4.54, so CervoMed's price volatility has been lower than the market average.

Beta (5Y)	-4.54
52-Week Price Change	-48.83%
50-Day Moving Average	3.44
200-Day Moving Average	5.85
Relative Strength Index (RSI)	51.73
Average Volume (20 Days)	16,119,292

Short Selling Information

The latest short interest is 343,846, so 2.54% of the outstanding shares have been sold short.

Short Interest	343,846
Short Previous Month	262,806
Short % of Shares Out	2.54%
Short % of Float	3.58%
Short Ratio (days to cover)	0.59

Income Statement

In the last 12 months, CervoMed had revenue of $2.09 million and -$30.04 million in losses. Loss per share was -$3.27.

Revenue	2.09M
Gross Profit	-20.02M
Operating Income	-31.10M
Pretax Income	-30.04M
Net Income	-30.04M
EBITDA	n/a
EBIT	-31.10M
Loss Per Share	-$3.27

Full Income Statement

Balance Sheet

The company has $12.92 million in cash and n/a in debt, giving a net cash position of $12.92 million or $0.96 per share.

Cash & Cash Equivalents	12.92M
Total Debt	n/a
Net Cash	12.92M
Net Cash Per Share	$0.96
Equity (Book Value)	10.62M
Book Value Per Share	1.15
Working Capital	10.62M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-27.57M
Capital Expenditures	n/a
Depreciation & Amortization	n/a
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,488.86%
Pretax Margin	-1,437.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.45%
Shareholder Yield	-5.45%
Earnings Yield	-63.63%
FCF Yield	n/a

Analyst Forecast

The average price target for CervoMed is $19.50, which is 458.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.50
Price Target Difference	458.74%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of -6.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.42
Piotroski F-Score	1